Multitask Learning on Graph Convolutional Residual Neural Networks for Screening of Multitarget Anticancer Compounds

Thanh-Hoang Nguyen-Vo1, Trang T T Do1, Binh P Nguyen2

  • 1Ho Chi Minh City Open University, 97 Vo Van Tan, District 3, Ho Chi Minh City 70000, Vietnam.

Insights

A new computational model, iACP-GCR, identifies multitarget anticancer compounds using graph convolutional residual neural networks. This approach accelerates the discovery of potential anticancer drugs by outperforming existing methods.

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Bioinformatics

Background:

  • Experimental screening for anticancer drugs is time-consuming and resource-intensive.
  • Computational methods are needed to accelerate the identification of potential anticancer compounds.
  • Multitarget drug discovery aims to identify compounds effective against multiple cancer types.

Purpose of the Study:

  • To develop an advanced computational model for identifying multitarget anticancer compounds.
  • To improve the efficiency and accuracy of anticancer drug candidate screening.
  • To provide a publicly accessible tool for researchers.

Main Methods:

  • Utilized multitask learning on graph convolutional residual neural networks (GCRNs) with two shortcut connection types.
  • Trained and evaluated the iACP-GCR model on the NCI-60 dataset, encompassing nine cancer types.
  • Compared the model's performance against three advanced computational multitask learning methods.

Main Results:

  • The iACP-GCR model demonstrated superior performance compared to existing advanced computational methods.
  • The integration of dual shortcut connections enhanced prediction efficiency.
  • The model successfully identified multitarget anticancer compounds with high accuracy.

Conclusions:

  • iACP-GCR offers a powerful and efficient computational approach for anticancer drug discovery.
  • The model's effectiveness in identifying multitarget compounds holds significant promise for cancer therapy.
  • A public web server has been deployed to facilitate broader research community access and utilization.

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...